JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 565
Type: Roundtables
Date/Time: Wednesday, August 12, 2015 : 12:30 PM to 1:50 PM
Sponsor: Biopharmaceutical Section
Abstract #316716
Title: Social Media and Drug Trials
Author(s): Darcy Hille* and T. Ceesay
Companies: Merck and Merck
Keywords: clinical trials ; blinding ; social media ; data monitoring committee
Abstract:

Blinding has been a central principal of clinical trials for decades. In most blinded trials, the participants, outcome assessors, and sponsor do not know the treatment assignment. However, social media such as Facebook may put the blinding in jeopardy. Some patients blog and post their clinical trial experiences. This may have an influence on other patients in the same trial, or other patients' willingness to join a trial. Is the trial sponsor or data-monitoring committee responsible for monitoring these activities? What, if anything, can be done to mitigate the negative impact on blinding?

Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home